chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Pain in extremity
Clinical narrative: immediately after the vaccination, for both doses, there was a significant sensation of pressure in chest that lasted approximately 3-5 minutes, then went away.; No other side effects other than a sore arm; This is a spontaneous report from a non-contactable consumer,  A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration on 20Apr2021 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received other medications (unspecified) within 2 weeks of vaccination. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation and experienced significant sensation of pressure in the chest that lasted approximately 3-5 minutes, then went away. On 20Apr2021 immediately after the vaccination, the patient experienced a significant sensation of pressure in the chest that lasted approximately 3-5 minutes, then went away. There were no other side effects other than a sore arm. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events significant sensation of pressure in the chest that lasted approximately 3-5 minutes was recovered on 20Apr2021, while the event sore arm was recovered on an unknown date in 2021.  No follow-up attempts are possible. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Ear pain, Eye irritation, Fatigue, Nausea
Clinical narrative: This is a spontaneous report from a contactable consumer. A 67-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 20May2021 at 05:15 (at the age of 67-year-old), as a single dose for COVID-19 immunisation. Medical history included COVID-19 and the patient had a history of allergy to codeine. Concomitant medications were not reported. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21May2021 at 03:00, the patient experienced nausea, body aches, earache, sore throat, eyes burning, fever, extreme fatigue and heaviness in chest. It lasted 48 hours. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events of nausea, body aches, earache, sore throat, eyes burning, fever, extreme fatigue and heaviness in chest were recovered on an unknown date in May2021.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain, Pyrexia
Clinical narrative: This is a spontaneous report from a contactable consumer. A 67-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 20May2021 at 05:15 (at the age of 67-year-old), as a single dose for COVID-19 immunisation. Medical history included COVID-19 and the patient had a history of allergy to codeine. Concomitant medications were not reported. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21May2021 at 03:00, the patient experienced nausea, body aches, earache, sore throat, eyes burning, fever, extreme fatigue and heaviness in chest. It lasted 48 hours. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events of nausea, body aches, earache, sore throat, eyes burning, fever, extreme fatigue and heaviness in chest were recovered on an unknown date in May2021.
Sex: F
Vaccine: COVID19
Symptoms: Abnormal dreams, Myalgia, Pyrexia
Clinical narrative: strange dreams; fever; myalgia; This is a spontaneous report from a contactable physician (patient) communicated to a Pfizer sales representative.  An adult female (pregnant: unknown) patient received dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as DOSE NUMBER UNKNOWN, single for COVID-19 immunisation. The patient medical history was not reported. The patient did not receive any concomitant medications. On an unspecified date, patient experienced strange dreams, fever and myalgia. At the time of report, event outcome was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected. .
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Epistaxis
Clinical narrative: Nose bleed; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 35-years-old male patient received bnt162b2 (BNT162B2, Formulation: Solution for injection), via an unspecified route of administration on 26May2021 17:00 (Batch/Lot Number: UNKNOWN) as DOSE NUMBER UNKNOWN, SINGLE (at the age of 35-year-old) for covid-19 immunisation. Medical history of the patient was reported as none. The patient did not receive any concomitant medications. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had nose bleed on 26May2021 18:15. Therapeutic measures were not taken as a result of this event. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The outcome of event nose bleed was unknown.  Follow-up attempts completed. No further information is expected.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Fatigue, Headache, Hypogeusia, Increased upper airway secretion
Clinical narrative: This is a spontaneous report from a non-contactable consumer or other non hcp (patient himself). A 63-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: ERB729; Expiration date: unknown) via an unspecified route of administration, administered in Arm Left on 20Apr2021 10:15 (at the age of 63-years-old) as DOSE 2, SINGLE for COVID-19 immunization. The patient medical history was none. Patient had not known allergies. Concomitant medication included famotidine (PEPCID AC) taken for an unspecified indication. The patient had previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: EP7534; Expiration date: unknown) via an unspecified route of administration, administered in Arm Left on 02Apr2021 10:00 (at the age of 63-years-old) as DOSE 1, SINGLE for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. On 20Apr2021 12:00 patient experienced fatigue, swollen lymph nodes in neck, red eyes, cough, drainage on left side of throat, extreme soreness in arm, headache, reduced sense of taste. Patient did not receive any treatment for AEs. The patient underwent lab tests and procedures which included SARS-COV-2 test (Nasal Swab/ QuickVue) post the vaccination on 26May2021 which resulted as negative. The outcome of all events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy, Ocular hyperaemia, Pain in extremity, SARS-CoV-2 test
Clinical narrative: This is a spontaneous report from a non-contactable consumer or other non hcp (patient himself). A 63-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: ERB729; Expiration date: unknown) via an unspecified route of administration, administered in Arm Left on 20Apr2021 10:15 (at the age of 63-years-old) as DOSE 2, SINGLE for COVID-19 immunization. The patient medical history was none. Patient had not known allergies. Concomitant medication included famotidine (PEPCID AC) taken for an unspecified indication. The patient had previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: EP7534; Expiration date: unknown) via an unspecified route of administration, administered in Arm Left on 02Apr2021 10:00 (at the age of 63-years-old) as DOSE 1, SINGLE for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. On 20Apr2021 12:00 patient experienced fatigue, swollen lymph nodes in neck, red eyes, cough, drainage on left side of throat, extreme soreness in arm, headache, reduced sense of taste. Patient did not receive any treatment for AEs. The patient underwent lab tests and procedures which included SARS-COV-2 test (Nasal Swab/ QuickVue) post the vaccination on 26May2021 which resulted as negative. The outcome of all events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Diarrhoea, Feeling abnormal, Headache
Clinical narrative: Joint pain; chills; headache; nausea; diarrhea; feel so bad; This is a spontaneous report from a non-contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;  formulation: solution for injection Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 04May2021 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis, degenerative disc disease and obesity. The patient was allergic to reactive oxygen species (ROS). Concomitant medications were not reported. The patient previously took sage and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04May2021, the patient experienced joint pain, chills, headache, nausea, diarrhea and felt so bad. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events of joint pain, chills, headache, nausea, diarrhea and feel so bad were recovered on an unknown date of May2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: Joint pain; chills; headache; nausea; diarrhea; feel so bad; This is a spontaneous report from a non-contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;  formulation: solution for injection Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 04May2021 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis, degenerative disc disease and obesity. The patient was allergic to reactive oxygen species (ROS). Concomitant medications were not reported. The patient previously took sage and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04May2021, the patient experienced joint pain, chills, headache, nausea, diarrhea and felt so bad. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events of joint pain, chills, headache, nausea, diarrhea and feel so bad were recovered on an unknown date of May2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Pruritus, Rash
Clinical narrative: Allergic reaction to the shot; Rash; Itching; This is a spontaneous report from a contactable consumer or other non hcp. A 53-year-old non-pregnant female patient received bnt162b2 (BNT162B2, Formulation: solution for injection, Batch/Lot Number and Expiration date was not reported) via an unspecified route of administration in Arm Left (age at vaccination 53-Year-old) on 21May2021 09:30 as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunization. Medical history included sulfonamide allergy. The patient's concomitant medications were not reported. The patient previously took influenza vaccine and polysorbate 80 and experienced drug hypersensitivity. On 21May2021 09:45 the patient experienced allergic reaction to the shot, rash and itching. Therapeutic measures were taken for the events and included treatment with antihistamines. On unknown date in May2021 the events were resolved.  The lot number for the vaccine [BNT162b2] was not provided and will be requested during follow up.  The lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chills, Fatigue, Headache, Pyrexia
Clinical narrative: Middle back pains; Headache; Fatigue; Chills; Low grade fever; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received (not pregnant at the time of vaccination) first dose of BNT162B2 (PFIZER-BIONTECH COVID -19 VACCINE, solution for injection, Lot Number: unknown, Expiry date: not reported) via an unspecified route of administration, administered in left arm on 24May2021 at 12:15 (58-year-old at the time of vaccination) as dose 1, single for COVID-19 immunization. Medical history include Allergy NOS. Concomitant medications included herbal remedies (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date. The patient had allergies to medications, food or other products (unspecified). Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27May2021 at 01:00, the patient experienced middle back pains, headache, fatigue, chills and low-grade fever. The events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events middle back pains, headache, fatigue, chills and low-grade fever was not recovered at the time of this report.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Cough, Dizziness, Dysuria
Clinical narrative: Coughing; Sore and stuff lungs; Entire body aches; Entire body shivers; Exhaustion; Dizzy; Pain in groin when urinating; Pain in groin when urinating; Increased pain in shoulder from previous impairment; Increased pain in head from previous impairment; Now every time I blow or clean my nose there is blood in it; Sore and stuff lungs; This is a spontaneous report received from a contactable consumer (patient) or other non hcp. A 31-years-old male patient received bnt162b2 (BNT162B2, Formulations: solution for injection), via an unspecified route of administration on 25May2021 11:45 (at the age of 31-years-old) (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient medical history was not reported. Concomitant medication included lisdexamfetamine mesilate (VYVANSE) taken for an unspecified indication, start and stop date were not reported. The patient previously took compazine [prochlorperazine edisylate] and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26May2021 at 04:00, the patient experienced coughing, sore and stuff lungs, entire body aches and shivers, exhaustion, dizzy, pain in groin when urinated, increased pain in shoulder and head from previous impairment. Most of the events subsided within 24 hours except cough, achey lungs and every time, when the patient blow or clean the nose there is blood in it. No therapeutic measures were taken as a result of these events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The outcome of events coughing, sore and stuff lungs, now every time i blow or clean my nose there is blood in it was resolving and other events was resolved on 27May2021.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Epistaxis, Fatigue, Groin pain, Headache, Lung disorder
Clinical narrative: Coughing; Sore and stuff lungs; Entire body aches; Entire body shivers; Exhaustion; Dizzy; Pain in groin when urinating; Pain in groin when urinating; Increased pain in shoulder from previous impairment; Increased pain in head from previous impairment; Now every time I blow or clean my nose there is blood in it; Sore and stuff lungs; This is a spontaneous report received from a contactable consumer (patient) or other non hcp. A 31-years-old male patient received bnt162b2 (BNT162B2, Formulations: solution for injection), via an unspecified route of administration on 25May2021 11:45 (at the age of 31-years-old) (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient medical history was not reported. Concomitant medication included lisdexamfetamine mesilate (VYVANSE) taken for an unspecified indication, start and stop date were not reported. The patient previously took compazine [prochlorperazine edisylate] and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26May2021 at 04:00, the patient experienced coughing, sore and stuff lungs, entire body aches and shivers, exhaustion, dizzy, pain in groin when urinated, increased pain in shoulder and head from previous impairment. Most of the events subsided within 24 hours except cough, achey lungs and every time, when the patient blow or clean the nose there is blood in it. No therapeutic measures were taken as a result of these events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The outcome of events coughing, sore and stuff lungs, now every time i blow or clean my nose there is blood in it was resolving and other events was resolved on 27May2021.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pulmonary pain
Clinical narrative: Coughing; Sore and stuff lungs; Entire body aches; Entire body shivers; Exhaustion; Dizzy; Pain in groin when urinating; Pain in groin when urinating; Increased pain in shoulder from previous impairment; Increased pain in head from previous impairment; Now every time I blow or clean my nose there is blood in it; Sore and stuff lungs; This is a spontaneous report received from a contactable consumer (patient) or other non hcp. A 31-years-old male patient received bnt162b2 (BNT162B2, Formulations: solution for injection), via an unspecified route of administration on 25May2021 11:45 (at the age of 31-years-old) (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient medical history was not reported. Concomitant medication included lisdexamfetamine mesilate (VYVANSE) taken for an unspecified indication, start and stop date were not reported. The patient previously took compazine [prochlorperazine edisylate] and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26May2021 at 04:00, the patient experienced coughing, sore and stuff lungs, entire body aches and shivers, exhaustion, dizzy, pain in groin when urinated, increased pain in shoulder and head from previous impairment. Most of the events subsided within 24 hours except cough, achey lungs and every time, when the patient blow or clean the nose there is blood in it. No therapeutic measures were taken as a result of these events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The outcome of events coughing, sore and stuff lungs, now every time i blow or clean my nose there is blood in it was resolving and other events was resolved on 27May2021.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash macular
Clinical narrative: Rash burning red spots on neck; Burning red spots on neck; This is a spontaneous report from a contactable consumer or other non HCP.  A 35-years-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Batch/Lot Number: UNKNOWN), via an unspecified route of administration on 24May2021 DOSE 2, SINGLE for covid-19 immunization. The patient medical history included first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Batch/Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. The patient received other medication in two weeks included body scrub. It was unknown whether the patient received any other vaccine within four weeks prior to the COVID vaccine. On an unknown date in May2021, the patient experienced rash burning red spots on neck (rash) and burning red spots on neck (rash macular) for 4 days post shot. The clinical outcome of rash and rash macular was recovered on an unknown date in May2021.  No follow-up attempts are possible; information about lot/batch number could not be obtained. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Myalgia, Nausea
Clinical narrative: Chills; Muscle pain; Joint pain; Nausea; Arm pain; Fever; Headaches; This is a spontaneous report from a contactable other hcp, the patient. A 39-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH m-RNA COVID-19 VACCINE, Solution for injection), dose 1 intramuscular, administered in Arm Left on 27May2021 17:45 (at the age of 39-years-old) (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines in four weeks. The patient did not receive any concomitant medications in two weeks. On an unknown date in May2021, the patient experienced chills, muscle pain, joint pain, nausea, arm pain, fever, and headaches. It was unknown whether any therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events of chills, muscle pain, joint pain, nausea, arm pain, fever and headaches were unknown at the time of this report.  Follow-up attempts completed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Chills; Muscle pain; Joint pain; Nausea; Arm pain; Fever; Headaches; This is a spontaneous report from a contactable other hcp, the patient. A 39-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH m-RNA COVID-19 VACCINE, Solution for injection), dose 1 intramuscular, administered in Arm Left on 27May2021 17:45 (at the age of 39-years-old) (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines in four weeks. The patient did not receive any concomitant medications in two weeks. On an unknown date in May2021, the patient experienced chills, muscle pain, joint pain, nausea, arm pain, fever, and headaches. It was unknown whether any therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events of chills, muscle pain, joint pain, nausea, arm pain, fever and headaches were unknown at the time of this report.  Follow-up attempts completed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: fever for two days; This is a spontaneous report from a non-contactable consumer or other non hcp, patient.    A 32-years-old male patient received bnt162b2 (BNT162B2, solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on 22May2021 as dose 2, single for covid-19 immunisation.  The patient medical history was not reported. The historical vaccine includes bnt162b2 (BNT162B2, solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 01May2021 as dose 1, single for covid-19 immunisation. Concomitant medication(s) included paracetamol (TYLENOL) taken for an unspecified indication, start and stop date were not reported. No COVID prior vaccination. It was unknown if COVID tested post vaccination. On 23May2021, the patient had a fever for two days since the second dose of the vaccine. The patient took Tylenol and had since recovered from the fever. The outcome of event was recovered on an unspecified date in 2021.    Follow-up attempts completed. No further information expected
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Malaise, Pityriasis rosea, Pruritus
Clinical narrative: Developed a papulosquamous rash across chest and back.; Appeared as pityriasis rosea with larger patch; Very itchy; Malaise; Chills; Headache; This is a spontaneous report from a contactable physician reported for a patient. A 26-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: not reported) via an unspecified route of administration on 24May2021 (at the age of 26-years-old) as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24May2021, initially after the vaccination, the patient experienced malaise, chills and headache for 24 hours. The patient felt fine for the next two days. On 27May2021, evening of day 4, the patient developed papulosquamous rash across chest and back which appeared as pityriasis rosea with larger patch and surrounding smaller papulosquamous lesions which was described as very itchy. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events which included treatment with benadryl and steroid cream. The clinical outcome of the events malaise, chills and headache were resolved on 25May2021, while the outcome of the events papulosquamous rash across chest and back, appeared as pityriasis rosea and very itchy were resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Rash papulosquamous
Clinical narrative: Developed a papulosquamous rash across chest and back.; Appeared as pityriasis rosea with larger patch; Very itchy; Malaise; Chills; Headache; This is a spontaneous report from a contactable physician reported for a patient. A 26-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: not reported) via an unspecified route of administration on 24May2021 (at the age of 26-years-old) as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24May2021, initially after the vaccination, the patient experienced malaise, chills and headache for 24 hours. The patient felt fine for the next two days. On 27May2021, evening of day 4, the patient developed papulosquamous rash across chest and back which appeared as pityriasis rosea with larger patch and surrounding smaller papulosquamous lesions which was described as very itchy. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events which included treatment with benadryl and steroid cream. The clinical outcome of the events malaise, chills and headache were resolved on 25May2021, while the outcome of the events papulosquamous rash across chest and back, appeared as pityriasis rosea and very itchy were resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Diarrhoea, Dizziness, Pyrexia
Clinical narrative: Diarrhea; Fever; Chills; Weakness; Dizziness; This is a spontaneous report from a contactable other healthcare professional, (patient). A 31-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in May2021 (at the age of 31-years-old) as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunisation. The patient had not reported any other health issues. The patient had no known allergies to medications, food or other products. Concomitant medications included aciclovir (ACYCLOVIR), biotin (MANUFACTURER UNKNOWN), spironolactone (MANUFACTURER UNKNOWN) and ascorbic acid (VITAMIN C) pills and colagen (MANUFACTURER UNKNOWN); from an unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On an unknown date in May2021, the patient experienced diarrhea since the day of the vaccine (4 days), fever the next day of the vaccine, chills, weakness and dizziness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of fever and included treatment with naproxen (MANUFACTURER UNKNOWN). The clinical outcomes of the events diarrhea, fever, chills, weakness and dizziness were resolved on an unknown date in May2021.   This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Bone disorder, Cough, Nasopharyngitis
Clinical narrative: had received in last Saturday but after the Saturday I  have cold; in my left hip much pain; Cough; Yes I want to know what happened in my chin; This is a spontaneous report from a contactable consumer (patient). A patient of an unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number and Expiry Date was Unknown), via an unspecified route of administration on an unspecified date in May2021 as DOSE 2, SINGLE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number was not reported, Expiry Date: Unknown), via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for COVID-19 immunisation. On an unspecified date in May2021, the patient had received on last saturday but after the saturday patient had cold, in patient left hip much pain, cough and yes patient want to know what happened in chin. The outcome of the events was unknown.    Information about lot/batch number has been requested. No follow-up attempts are completed; Information about lot/batch number cannot be obtained.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure decreased, Blood pressure measurement, Dizziness, Headache
Clinical narrative: Headache; dizziness; low blood pressure reading; This is a spontaneous report from a contactable consumer, the patient.  An 18-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection Lot Number: unknown) via an unspecified route of administration in the left arm on 03May2021 at 16:00 (at the age of 18-years-old) as a dose 1, single for COVID-19 immunisation. The patient medical history was not reported. The patient had no known allergies. The patient did not receive any other medications within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications were not reported. On 28May2021 at 18:00, the patient experienced headache, dizziness and low blood pressure reading. The events resulted in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. No therapeutic measures were taken as a result of events. The patient underwent lab tests which included blood pressure measurement as low blood pressure reading on 28May2021. The clinical outcome of the events was not recovered at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow-up.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Body temperature, Chills, Decreased appetite
Clinical narrative: Felt fine when first woke, but had light nausea within 15 min.  Nausea went away after eating breakfast,; Fever of 100.3; Chills; body/joint aches; Lack of appetite; Headache; body/joint aches; Sore throat; Weakness/ Lack of energy; Sweat a lot while sleeping; Patient received the second dose of vaccine on 14May2021; This is a spontaneous report from a contactable consumer (patient). A 33-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number was not reported), via an unspecified route of administration, administered in right arm on 14May2021 at 17:00 (at the age of 33-years) as dose 2, single for COVID-19 immunization. The patients medical history included penicillin allergy. Concomitant medications included ibuprofen sodium; vitamin d nos; fish oil (OMEGA 3 6 9 [FISH OIL]) taken for an unspecified indication, start and stop date were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number was not reported), via an unspecified route of administration, administered in left arm on 30Apr2021 at 17:00 (at the age of 33-years) as dose 1, single for COVID-19 immunization. The patient previously took amoxicillin (MANUFACTURER UNKNOWN)  and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15May2021 at 08:30, the patient felt fine when first woke up, but had light nausea within 15 minutes. The nausea went away after eating breakfast, but from there developed weakness/lack of energy, fever of 100.3, chills, body/joint aches, sore throat, lack of appetite and headache. The fever was lower by the evening. On 15May2021, the patient also sweat a lot while sleeping. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. On 15May2021, the patient underwent lab test of body temperature: 100.3. The outcome of the event light nausea was recovered on 15May2021, while that of weakness, lack of energy, fever of 100.3, chills, body/joint aches, sore throat, lack of appetite, headache and sweat a lot while sleeping were recovered on 16May2021.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Inappropriate schedule of product administration, Nausea, Night sweats, Oropharyngeal pain
Clinical narrative: Felt fine when first woke, but had light nausea within 15 min.  Nausea went away after eating breakfast,; Fever of 100.3; Chills; body/joint aches; Lack of appetite; Headache; body/joint aches; Sore throat; Weakness/ Lack of energy; Sweat a lot while sleeping; Patient received the second dose of vaccine on 14May2021; This is a spontaneous report from a contactable consumer (patient). A 33-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number was not reported), via an unspecified route of administration, administered in right arm on 14May2021 at 17:00 (at the age of 33-years) as dose 2, single for COVID-19 immunization. The patients medical history included penicillin allergy. Concomitant medications included ibuprofen sodium; vitamin d nos; fish oil (OMEGA 3 6 9 [FISH OIL]) taken for an unspecified indication, start and stop date were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number was not reported), via an unspecified route of administration, administered in left arm on 30Apr2021 at 17:00 (at the age of 33-years) as dose 1, single for COVID-19 immunization. The patient previously took amoxicillin (MANUFACTURER UNKNOWN)  and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15May2021 at 08:30, the patient felt fine when first woke up, but had light nausea within 15 minutes. The nausea went away after eating breakfast, but from there developed weakness/lack of energy, fever of 100.3, chills, body/joint aches, sore throat, lack of appetite and headache. The fever was lower by the evening. On 15May2021, the patient also sweat a lot while sleeping. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. On 15May2021, the patient underwent lab test of body temperature: 100.3. The outcome of the event light nausea was recovered on 15May2021, while that of weakness, lack of energy, fever of 100.3, chills, body/joint aches, sore throat, lack of appetite, headache and sweat a lot while sleeping were recovered on 16May2021.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Felt fine when first woke, but had light nausea within 15 min.  Nausea went away after eating breakfast,; Fever of 100.3; Chills; body/joint aches; Lack of appetite; Headache; body/joint aches; Sore throat; Weakness/ Lack of energy; Sweat a lot while sleeping; Patient received the second dose of vaccine on 14May2021; This is a spontaneous report from a contactable consumer (patient). A 33-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number was not reported), via an unspecified route of administration, administered in right arm on 14May2021 at 17:00 (at the age of 33-years) as dose 2, single for COVID-19 immunization. The patients medical history included penicillin allergy. Concomitant medications included ibuprofen sodium; vitamin d nos; fish oil (OMEGA 3 6 9 [FISH OIL]) taken for an unspecified indication, start and stop date were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number was not reported), via an unspecified route of administration, administered in left arm on 30Apr2021 at 17:00 (at the age of 33-years) as dose 1, single for COVID-19 immunization. The patient previously took amoxicillin (MANUFACTURER UNKNOWN)  and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15May2021 at 08:30, the patient felt fine when first woke up, but had light nausea within 15 minutes. The nausea went away after eating breakfast, but from there developed weakness/lack of energy, fever of 100.3, chills, body/joint aches, sore throat, lack of appetite and headache. The fever was lower by the evening. On 15May2021, the patient also sweat a lot while sleeping. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. On 15May2021, the patient underwent lab test of body temperature: 100.3. The outcome of the event light nausea was recovered on 15May2021, while that of weakness, lack of energy, fever of 100.3, chills, body/joint aches, sore throat, lack of appetite, headache and sweat a lot while sleeping were recovered on 16May2021.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Musculoskeletal stiffness, SARS-CoV-2 test
Clinical narrative: After 2nd injection and more recently I noticed that My left arm is stiffer with severe joint p; joint pain and discomfort.; This is a spontaneous report from a contactable consumer (patient). A 55-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot number and Expiry date was not reported), via an unspecified route of administration, administered in arm left on 01May2021 at 12:15 (age at vaccination 55-years-old) as DOSE 2, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot number, Expiry date was not reported), via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunization with after the first injection, I noticed that I can barely move my arm. Lots of pain and hard join movement. The patient experienced after 2nd injection and more recently i noticed that my left arm is stiffer with severe joint pain and discomfort on an unspecified date. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on an unspecified date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021634352 similar report from same reporter
Sex: U
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: I have a rash all over my body, my chest and all my arm and all my legs; I am broke up real bad and this above all my neck and my chest; This is a spontaneous report from a contactable consumer(patient). A patient of unspecified age and gender received a second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number and Expiry date were not reported) via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously received a first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number and Expiry date were not reported) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. On an unspecified date the patient experienced i have a rash all over my body, my chest and all my arm and all my legs; i am broke up real bad and this above all my neck and my chest. The outcome of the event was unknown at the time of the report.  No follow-up attempts are needed. No lot/batch number cannot be obtained.